Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 0 | 0 | 2,053 | 148 | 189 |
| Gross Profit | N/A | N/A | 2,053 | 148 | 189 |
| Operating Expenses | 10,445 | 7,202 | 6,993 | 6,660 | 6,507 |
| Operating Income | -10,445 | -7,202 | -4,940 | -6,512 | -6,318 |
| Other Income | 53 | 47 | 5 | -88 | -129 |
| Pre-tax Income | -10,392 | -7,155 | -4,935 | -6,600 | -6,447 |
| Net Income Continuous | -10,392 | -7,155 | -4,935 | -6,600 | -6,447 |
| Minority Interests | 1 | 4 | -9 | 1 | 1 |
| Net Income | $-10,391 | $-7,159 | $-4,926 | $-6,601 | $-6,448 |
| EPS Basic Total Ops | -0.64 | -0.51 | -0.65 | -0.68 | -0.69 |
| EPS Basic Continuous Ops | -0.64 | -0.51 | -0.65 | -0.68 | -0.69 |
| EPS Diluted Total Ops | -0.64 | -0.51 | -0.65 | -0.68 | -0.69 |
| EPS Diluted Continuous Ops | -0.64 | -0.51 | -0.65 | -0.68 | -0.69 |
| EBITDA(a) | $-10,032 | $-6,854 | $-4,617 | $-6,061 | $-5,833 |